Healthy subjects(including MCI)
Conditions
Interventions
Oral intake of the test foods (high dose) (8 capsules in a day for 12 weeks)
Oral intake of the test foods (low dose) (8 capsules in a day for 12 weeks)
Oral intake of the placebo foods (8 capsules in
Sponsors
Tashikani Plus Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy subjects with MMSE results by screening test of 24 points or more(including MCI) 2) Healthy adults aged 40 to 70 years old. 3) Gender: No preference 4) Subjects without smoking habits 5) Subjects who do not have a habit of taking a meal containing a large amount of the tested food 6) Subjects who do not suffer from lifestyle diseases (high blood pressure, diabetes etc.), rheumatism, liver disorders, renal disorders, other chronic diseases 7) Subjects who have no history of treatment of malignant tumor, heart failure, myocardial infarction 8) Subjects who have no history of allergy to test foods / medicines 9) Subjects who do not take medication for Outpatient treatment 10) Subjects who do not regularly use health foods 11) Subjects giving written informed consent
Exclusion criteria
Exclusion criteria: 1) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period 2) Subjects who are participating the other clinical tests. Subjects who participated within 3-month prior to the current study 3) Subjects who do not comply with instructions from the doctor or medical staff 4) Others who have been determined ineligible by investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of cognitive function by Cognitrax test and eye tracking at 0 week and at 6,12 weeks | — |
Countries
Japan
Contacts
Public ContactTaisuke Fukaya
Tashikani Plus Co., Ltd CEO
Outcome results
None listed